trending Market Intelligence /marketintelligence/en/news-insights/trending/dwOebbXKxlEu_6wSx0QoFg2 content esgSubNav
In This List

Catalyst Biosciences chairman stepping down; replacement named

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Catalyst Biosciences chairman stepping down; replacement named

Barry Selick is stepping down as a board member and chairman of Catalyst Biosciences Inc. on Feb. 15, 2018.

Current board member Augustine Lawlor will replace Selick as chairman.

Also, the company appointed Edward Williams as a board member, effective Jan. 1, 2018.

Williams was most recently senior vice president of biopharmaceuticals at Novo Nordisk Inc.